Modification of electroshock fighting by drugs known to interact with dopaminergic and noradrenergic neurons in normal and brain lesioned rats.
D000374:Aggression / Q000187:drug effects*; D000547:Amantadine / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001921:Brain / Q000166:cytology / Q000502:physiology*; D004050:Ditiocarb / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D004597:Electroshock; D006801:Humans; D007099:Imipramine / Q000494:pharmacology; D007980:Levodopa / Q000494:pharmacology; D008297:Male; D009474:Neurons / Q000187:drug effects*; D009638:Norepinephrine / Q000502:physiology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology
D007980:Levodopa; D012110:Reserpine; D004050:Ditiocarb; D000547:Amantadine; D001058:Apomorphine; D007099:Imipramine; D004298:Dopamine; D009638:Norepinephrine